Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Case Study: How one online pharmacy knowingly endangered U.S. consumers

March 2, 2017

A real example of one online pharmacy that was caught selling counterfeit medicines to U.S. consumers.

Read More

Guest Post: Epilepsy Foundation on rare diseases

March 1, 2017

Epilepsy is the fourth most common neurological disorder, affecting more than 3 million Americans.

Read More

How innovative medicines are benefiting countries across the globe

March 1, 2017

Our new Prescription Medicines: International Costs in Context explains how medicines benefit patients, health care systems, and the global economy.

Read More

Why drug importation threatens patient safety

February 28, 2017

A closer look at why drug importation proposals put patient safety at risk.

Read More

Rare Disease Day: Accelerating innovation for patients in need

February 28, 2017

The biopharmaceutical industry is committed to advancing novel therapies for the more than 30 million Americans suffering from a rare disease today.

Read More

Medicare Monday: There’s an agency called MedPAC?

February 27, 2017

MedPAC is an independent congressional agency that was created by the Balanced Budget Act of 1997.

Read More

Fact Check Friday: The truth about drug importation and patient safety

February 24, 2017

We’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients.

Read More

How do multiple sclerosis patients define value?

February 24, 2017

Real Endpoints conducted research that found significant variability in treatment preferences among MS patients.

Read More

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

February 24, 2017

Leaders across the health care continuum gathered yesterday in Washington, D.C., to discuss ways to improve payment and delivery systems in the private market and opportunities for producing and rewarding better value for patients. The meeting was convened by The Value Collaborative, an initiative of America’s biopharmaceutical companies, in partnership with Morning Consult.

Read More

PPA: 2016 in review

February 23, 2017

PPA helps connect millions of people with public and private patient assistance programs that provide prescription medicines for free or nearly free.

Read More